Home » People » Leadership

Leadership

HSCI has two faculty co-directors, appointed by the Provost, who have overall responsibility for running the Institute. The co-directors are Douglas Melton, who is the Thomas Dudley Cabot Professor of the Natural Sciences in the Faculty of Arts and Sciences and a Howard Hughes Medical Investigator; and David Scadden, Professor of Medicine at Harvard Medical School and Director of the Center for Regenerative Medicine at Massachusetts General Hospital.

The directors are advised by a faculty executive committee representing the Harvard schools and teaching hospitals. This committee is responsible for providing overall guidance to the Institute and for convening the various advisory subcommittees that will help to shape its strategy. These subcommittees include a grant review committee, with representatives from the main institutions involved in HSCI, as well as working groups in each of the areas of interest to HSCI.

Scientific Directors

Name Affiliation Email
Douglas A. Melton, PhD Harvard University Department of Stem Cell and Regenerative Biology
Howard Hughes Medical Institute		 dmelton@mcb.harvard.edu
David T. Scadden, MD Harvard University Department of Stem Cell and Regenerative Biology
Massachusetts General Hospital		 scadden.david@mgh.harvard.edu

Executive Director

Name Affiliation Email
Brock Reeve, MPhil, MBA Harvard Stem Cell Institute brock_reeve@harvard.edu

Executive Committee

Name Affiliation Email
Leonard Zon, MD, Chair Howard Hughes Medical Institute
Children's Hospital Boston		 zon@enders.tch.harvard.edu
Joseph V. Bonventre, MD, PhD Brigham and Women's Hospital jbonventre@partners.org
Kenneth R. Chien, MD, PhD Massachusetts General Hospital
Cardiovascular Research Center		 krchien@partners.org
George Daley, MD, PhD Boston Children's Hospital george.daley@childrens.harvard.edu
Susan Dymecki, MD, PhD Harvard Medical School dymecki@genetics.med.harvard.edu
Carla F. Kim, PhD Boston Children's Hospital carla.kim@childrens.harvard.edu
Jeffrey Macklis, MD Massachusetts General Hospital jeffrey_macklis@hms.harvard.edu
Andrew P. McMahon, PhD Faculty of Arts and Sciences, Harvard University amcmahon@mcb.harvard.edu
Jerome Ritz, MD Dana Farber Cancer Institute jerome_ritz@dfci.harvard.edu
Anthony Rosenzweig, MD Beth Israel Deaconess
Medical Center		 arosenzw@bidmc.harvard.edu
Lee Rubin, PhD Harvard University Department of Stem Cell and Regenerative Biology lee_rubin@harvard.edu
Ramesh Shivdasani, MD, PhD Dana-Farber Cancer Institute ramesh_shivdasani@dfci.harvard.edu
Amy Wagers, PhD Harvard University Department of Stem Cell and Regenerative Biology
Joslin Diabetes Center		 amy.wagers@joslin.harvard.edu

Scientific Advisory Board

Name Affiliation
Fred Appelbaum, MD, PhD Fred Hutchinson Cancer Research Center
Paul Berg, PhD Stanford University School of Medicine, Nobel Laureate
Mark C. Fishman, MD Novartis Institutes for BioMedical Research
Sir John Gurdon, PhD The Wellcome Trust, Cambridge University, Gurdon Institute
Zach W. Hall, PhD Former President, California Institute for Regenerative Medicine
Fiona Watt, DPhil Cambridge University, UK